VITAMIN B12 AND FOLATE BIOAVAILABILITY FROM TWO PRENATAL MULTIVITAMIN/MULTIMINERAL SUPPLEMENTS

 

 Buy Article Permissions and Reprints

ABSTRACT

In this crossover, single-blind study, the bioavailability of B₁₂ and folate, fasting and postprandially, was measured in 30 pregnant women for two prenatal multivitamin/multimineral supplements (Stuartnatal Plus^℗ and Materna^℗, Wyeth-Ayerst Pharmaceuticals, Philadelphia, PA) and a placebo. Blood samples were obtained before supplementation and at 1, 3, 6, and 8 hr after supplementation serum levels of the two vitamins were measured by radioimmunoassay. The maximum postabsorption serum level was multiplied by the total body plasma levels to obtain the total rate of body absorption. The absorption peak of both vitamins occurred at 3 hours after ingestion of a supplement. The total body absorption of the two vitamins was greater during fasting than it was postprandially. There was 30% greater B₁₂ absorption for Stuartnatal Plus (371 ± 56 vs. 285 ± 34 pmol) and 33% for Materna (315 ± 34 vs. 236 ± 4 pmol, p ≤ 0.05). Similarly, there was 117% greater folate absorption fasting for Stuartnatal Plus (163 ± 15 vs. 75 ± 15 nmol, p ≤ 0.001) and 57% greater absorption for Materna (207 ± 21 vs. 132 ± 13 nmol, p ≤ 0.01). Both vitamins were readily absorbed (within 3 hours) into the maternal hepatic portal circulation. The absorption of both vitamins was significantly less when ingested after the test meal than when fasting.

REFERENCES

• 1 MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council vitamin study.  Lancet . 1991;  338 131-137
  CrossrefPubMedGoogle Scholar
• 2 Smithells R W, Nevin N C, Seller M J. Further experience of vitamin supplementation for prevention of neural tube defect recurrences.  Lancet . 1983;  1 1027-1031
  PubMedGoogle Scholar
• 3 Czeil A E, Dudas I. Prevention of the first occurrence of neural tube defects by periconceptual vitamin supplementation.  N Engl J Med . 1992;  327 1832-1835
  PubMedGoogle Scholar
• 4 Mills J L, McParttin J M, Kirke P N. Homocysteine metabolism in pregnancies complicated by neural-tube defects.  Lancet . 1995;  345 149-151
  CrossrefPubMedGoogle Scholar
• 5 Kirke P M, Molloy A, Daly L E. Maternal plasma folate and vitamin B₁₂ are independent risk factors for neural tube defects.  Q J Med . 1983;  86 703-708
  PubMedGoogle Scholar
• 6 Scott J, Kirke P M, Molloy A, Daly L E. The role of folate in the prevention of neural tube defects.  Proc Nutr Soc . 1994;  53 631-636
  CrossrefPubMedGoogle Scholar
• 7 Sciver C R, Rosenderg L E. Amino Acid Metabolism and Its Disorders.  Philadelphia: Saunders 1973: 53
  Google Scholar
• 8 Brönstrup A, Hages M, Prinz-Langenohl, Pietrzik K. Effects of folic acid and combinations of folic acid and vitamin B12 on plasma homocysteine concentrations in healthy, young women.  Am J Clin Nutr . 1998;  68 1104-1110
  PubMedGoogle Scholar
• 9 Herbert V. Folate and neural tube defects.  Nutr Today . 1992;  27 30-33
  PubMedGoogle Scholar
• 10 Herbert V. Folate supplements should be appropriately labeled to protect consumers.  Pediatrics . 1994;  93 694-695
  PubMedGoogle Scholar
• 11 Herbert V. Vitamin B₁₂ . In: Ziegler EE, Filer LJ, eds. Present Knowledge in Nutrition 7th ed. Washington, DC: International Life Sciences Institute (ILSI) Press 1996: 191-205
  Google Scholar
• 12 Pfeiffer C M, Rogers L M, Bailey L B, Gregory III J F. Absorption of folate from fortified cereal-grain products and of supplemented folate consumed with or without food determined by using a dual-labeled stable-isotope protocol.  Am J Clin Nutr . 1997;  66 1388-1397
  PubMedGoogle Scholar
• 13 Bhandari S D, Gregory J F. Folic acid, 5-methyl-tetrahydrofolate and 5-formyl-tetrahydrofolate exhibit equivalent intestinal absorption, metabolism and in vivo kinetics in rats.  J Nutr . 1992;  122 1847-1854
  PubMedGoogle Scholar
• 14 Schuster D, Weimann H J, Muller J, Menke A, Menke G. Pharmacokinetics and relative bioavailability of iron and folic acid in healthy volunteers.  Arzneimittelforschung . 1993;  43 761-766
  PubMedGoogle Scholar
• 15 Dawson E B, McGanity W J. Iron bioavailability studies in teenage pregnancy.  Clin Ther . 1988;  10 429-435
  PubMedGoogle Scholar
• 16 Dawson E B, McGanity W J. Serum ferritin levels after multivitamin iron ingestion during teenage pregnancy.  Clin Ther . 1989;  11 151-160
  PubMedGoogle Scholar
• 17 Dawson E B, Dawson R, Behrens J, DeVora M A, McGanity W J. The bioavailability of iron in four prenatal multivitamin/multimineral supplements.  J Reprod Med . 1998;  43 133-140
  PubMedGoogle Scholar
• 18 Committee on Dietary Allowances, Food and Nutrition Board. Recommended Dietary Allowances 10th ed. Washington, DC: National Research Council, National Academy of Sciences; 1989
• 19 Anatomical Values for Reference Man. Elmsford, NY: Peramon Press Ltd; 1975: 229
• 20 Hytten F E, Leitch I. The Physiology of Human Pregnancy.  Philadelphia: FA Davis; 1964
  Google Scholar
• 21 Metz J, Festenstein H, Welch P. Effect of folic acid and vitamin B₁₂ supplementation on tests of folate and vitamin B₁₂ nutrition in pregnancy.  Am J Clin Nutr . 1965;  16 472-479
  PubMedGoogle Scholar
• 22 Hamfelt A, Tuvemo T. Pyridoxal phosphate and folic acid concentration in blood and erythrocyte aspartate amintransferase activity during pregnancy.  Clin Chim Acta . 1972;  41 287-298
  CrossrefPubMedGoogle Scholar
• 23 Dawson E B, McGanity W J. Protection of maternal iron stores in pregnancy.  J Reprod Med . 1987;  32 478-487
  PubMedGoogle Scholar
• 24 Chanarin I, Rothman D, Ward A, Perry J. Folate status and requirement in pregnancy.  Br Med J . 1985;  390-394
  PubMedGoogle Scholar
• 25 Bailey L B. Folate requirements and dietary recommendations. In: Bailey LB ed. Folate in Health and Disease. New York: Marcel Dekker, Inc 1995: 123-151
  Google Scholar
• 26 Coleman N. Addition of folic acid to staple foods as a selective nutrition intervention strategy.  Nutr Rev . 1982;  40 225-233
  PubMedGoogle Scholar